Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | %Female (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
280 | Advances in Pharmacological Sciences | journal | 0.676 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
279 | American Journal Geriatric Pharmacotherapy | journal | 1.348 Q1 | 63 | 0 | 139 | 0 | 535 | 128 | 3.48 | 0.00 | 0.00 | |
278 | Anales de la Real Academia Nacional de Medicina | journal | 0.100 Q4 | 7 | 0 | 113 | 0 | 0 | 113 | 0.00 | 0.00 | 0.00 | |
277 | Archives of Drug Information | journal | 0.368 Q3 | 12 | 0 | 11 | 0 | 17 | 11 | 2.75 | 0.00 | 0.00 | |
276 | BMC Clinical Pharmacology | journal | 0.644 Q2 | 43 | 0 | 53 | 0 | 146 | 53 | 2.59 | 0.00 | 0.00 | |
275 | BMC Pharmacology | journal | 1.120 Q1 | 48 | 0 | 38 | 0 | 140 | 38 | 2.82 | 0.00 | 0.00 | |
274 | Chemotherapie Journal | journal | 0.147 Q3 | 15 | 0 | 62 | 0 | 28 | 45 | 0.33 | 0.00 | 0.00 | |
273 | Chemotherapy Research and Practice | journal | 0.705 Q2 | 5 | 0 | 1 | 0 | 4 | 1 | 4.00 | 0.00 | 0.00 | |
272 | Clinical Pharmacist | journal | 0.100 Q4 | 11 | 0 | 313 | 0 | 5 | 201 | 0.01 | 0.00 | 0.00 | |
271 | Current Clinical Pharmacology | journal | 0.705 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
270 | Current Psychopharmacology | journal | 0.122 Q4 | 4 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
269 | Drug Benefit Trends | journal | 0.118 Q4 | 11 | 0 | 37 | 0 | 3 | 31 | 0.00 | 0.00 | 0.00 | |
268 | Drug Information Journal | journal | 0.444 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
267 | Enfermedades Emergentes | journal | 0.107 Q4 | 9 | 0 | 22 | 0 | 4 | 17 | 0.00 | 0.00 | 0.00 | |
266 | Farmaceutico Hospitales | journal | 0.155 Q3 | 3 | 0 | 35 | 0 | 3 | 22 | 0.14 | 0.00 | 0.00 | |
265 | Farmaceuticos de Atencion Primaria | journal | 0.104 Q4 | 2 | 0 | 61 | 0 | 2 | 42 | 0.02 | 0.00 | 0.00 | |
264 | Giornale Italiano di Farmacia Clinica | journal | 0.100 Q4 | 8 | 0 | 73 | 0 | 0 | 63 | 0.00 | 0.00 | 0.00 | |
263 | HIV Clinical Trials | journal | 1.096 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
262 | HIV Therapy | journal | 0.359 Q3 | 14 | 0 | 48 | 0 | 32 | 37 | 0.00 | 0.00 | 0.00 | |
261 | International Journal of Essential Oil Therapeutics | journal | 0.117 Q4 | 15 | 0 | 14 | 0 | 5 | 13 | 0.00 | 0.00 | 0.00 | |
260 | International Journal of Pharmaceutical Compounding | journal | 0.107 Q4 | 13 | 75 | 354 | 0 | 25 | 338 | 0.08 | 0.00 | 44.05 | |
259 | Japanese Journal of Psychopharmacology | journal | 0.102 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
258 | Klinik Psikofarmakoloji Bulteni | journal | 0.151 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
257 | Marmara Pharmaceutical Journal | journal | 0.236 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
256 | MeReC Bulletin | journal | 0.317 Q3 | 7 | 0 | 7 | 0 | 4 | 3 | 0.17 | 0.00 | 0.00 | |
255 | Methods and Findings in Experimental and Clinical Pharmacology | journal | 0.239 Q3 | 56 | 0 | 86 | 0 | 72 | 77 | 0.00 | 0.00 | 0.00 | |
254 | Methods in Pharmacology and Toxicology | book series | 0.112 Q4 | 14 | 0 | 44 | 0 | 7 | 41 | 0.16 | 0.00 | 0.00 | |
253 | Neuropsychopharmacology Reports | journal | 22 | 1 | 14 | 0 | 0 | 10 | 0.00 | 0.00 | 0.00 | ||
252 | NTP monograph | journal | 0.122 | 2 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
251 | Open Neuropsychopharmacology Journal | journal | 0.163 Q3 | 6 | 0 | 11 | 0 | 3 | 11 | 0.10 | 0.00 | 0.00 | |
250 | Perspectives in Medicinal Chemistry | journal | 0.121 Q4 | 17 | 0 | 5 | 0 | 2 | 5 | 0.00 | 0.00 | 0.00 | |
249 | Pharmaca | journal | 0.101 Q4 | 5 | 0 | 30 | 0 | 0 | 26 | 0.00 | 0.00 | 0.00 | |
248 | Pharmacien Hospitalier et Clinicien | journal | 0.176 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
247 | Pharmazie in Unserer Zeit | journal | 0.116 Q4 | 13 | 0 | 228 | 0 | 18 | 206 | 0.08 | 0.00 | 0.00 | |
246 | Psychopharmacology Bulletin | journal | 0.417 Q2 | 66 | 0 | 51 | 0 | 59 | 51 | 0.54 | 0.00 | 0.00 | |
245 | Recent Patents on Anti-Infective Drug Discovery | journal | 0.444 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
244 | Side Effects of Drugs Annual | book series | 0.100 Q4 | 9 | 0 | 157 | 0 | 1 | 8 | 0.00 | 0.00 | 0.00 | |
243 | Therapeutics, Pharmacology and Clinical Toxicology | journal | 0.103 Q4 | 4 | 0 | 102 | 0 | 8 | 100 | 0.08 | 0.00 | 0.00 | |
242 | Therapy | journal | 0.164 Q3 | 22 | 0 | 152 | 0 | 45 | 123 | 0.26 | 0.00 | 0.00 | |
241 | Open Toxinology Journal | journal | 0.306 Q3 | 2 | 1 | 1 | 55 | 2 | 1 | 2.00 | 55.00 | 50.00 | |
240 | Annals of Cancer Research and Therapy | journal | 0.115 Q4 | 7 | 5 | 37 | 95 | 5 | 37 | 0.09 | 19.00 | 12.50 | |
239 | Archivos Venezolanos de Farmacologia y Terapeutica (discontinued) | journal | 0.102 Q4 | 11 | 3 | 57 | 109 | 4 | 47 | 0.08 | 36.33 | 38.46 | |
238 | Research Journal of Pharmacology (discontinued) | journal | 0.148 Q3 | 10 | 7 | 50 | 111 | 16 | 50 | 0.25 | 15.86 | 28.57 | |
237 | Oral Therapeutics and Pharmacology | journal | 0.111 Q4 | 6 | 8 | 34 | 159 | 1 | 34 | 0.04 | 19.88 | 30.77 | |
236 | Journal of Experimental Pharmacology | journal | 0.129 Q4 | 23 | 1 | 3 | 166 | 2 | 3 | 0.50 | 166.00 | 100.00 | |
235 | WHO Drug Information | journal | 0.101 Q4 | 11 | 22 | 45 | 182 | 3 | 24 | 0.13 | 8.27 | 0.00 | |
234 | Pharma-Kritik (discontinued) | journal | 0.102 Q4 | 2 | 18 | 87 | 183 | 2 | 36 | 0.00 | 10.17 | 0.00 | |
233 | Clinical Research and Regulatory Affairs | journal | 0.139 Q4 | 18 | 8 | 44 | 200 | 18 | 38 | 0.19 | 25.00 | 35.71 | |
232 | Vaccines | journal | 85 | 2 | 0 | 202 | 0 | 0 | 0.00 | 101.00 | 33.33 | ||
231 | Journal of Applied Research | journal | 0.148 Q3 | 23 | 2 | 40 | 203 | 14 | 39 | 0.17 | 101.50 | 44.44 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®